Developing and comparing two different prognostic indexes for predicting disease-free survival of nonmetastatic breast cancer patients

被引:4
作者
Tokatli, Zehra Fusun [2 ]
Ture, Mevlut [1 ]
Omurlu, Imran Kurt [1 ]
Alas, Rusen Cosar [3 ]
Uzal, Mustafa Cem [3 ]
机构
[1] Adnan Menderes Univ, Dept Biostat & Med Informat, Fac Med, Aydin, Turkey
[2] Medicana Int, Dept Radiat Oncol, Istanbul, Turkey
[3] Trakya Univ, Dept Radiat Oncol, Fac Med, Edirne, Turkey
关键词
Breast cancer; survival tree; recursive partitioning; disease-free survival; prognostic index; INTERNATIONAL EXPERT CONSENSUS; GENE AMPLIFICATION; PRIMARY THERAPY; HER-2/NEU GENE; EXPRESSION; HIGHLIGHTS; RECURRENCE; PROTEIN;
D O I
10.3906/sag-0909-257
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To determine 2 different prognostic indexes (PI) for the differentiation of subgroups of nonmetastatic breast cancer patients with the Cox regression analysis and survival tree (ST) methods and the additional usage of the Kaplan-Meier estimates to investigate the predictive power of these methods. Materials and methods: Prognostic factors data were collected for 410 patients. The Cox regression analysis examines the relationship of the survival distribution and covariates. The ST method is a tree-structured survival analysis based on a recursive partitioning algorithm. In this study, Harrell's concordance indexes of models for training and test sets were computed. Furthermore, survival curves were estimated by the Kaplan-Meier method. Disease-free survival (DFS) was calculated from the time of initial diagnosis (initiation of the first treatment) to the first recurrence of disease. Results: After a median follow-up of 48 months, 100 (24.4%) patients have had at least 1 of the DFS events. In Cox regression analysis, we proposed the simple PI, which is a sum of axillary nodal and HER2/neu status. In the ST method, we identified 3 variables: HER2/neu, axillary nodal, and estrogen receptor status. The axillary nodal status was the most important determining factor for recurrence. Conclusion: We found that the PI of the ST and Cox regression methods had similar performance levels in predicting DFS, and the error rates of the models were close to each other in the training and test sets. Furthermore, we determined that the axillary nodal status and HER2/neu were the most important determining factors for prediction of DFS in breast cancer patients.
引用
收藏
页码:769 / 780
页数:12
相关论文
共 36 条
  • [1] AALTOMAA S, 1993, ONCOLOGY-BASEL, V50, P57
  • [2] Activation of Src kinase in primary colorectal carcinoma - An indicator of poor clinical prognosis
    Allgayer, H
    Boyd, DD
    Heiss, MM
    Abdalla, EK
    Curley, SA
    Gallick, GE
    [J]. CANCER, 2002, 94 (02) : 344 - 351
  • [3] [Anonymous], 1984, OLSHEN STONE CLASSIF, DOI 10.2307/2530946
  • [4] [Anonymous], 1997, AJCC CANC STAG MAN
  • [5] THE NOTTINGHAM-PROGNOSTIC-INDEX APPLIED TO 9,149 PATIENTS FROM THE STUDIES OF THE DANISH-BREAST-CANCER-COOPERATIVE-GROUP (DBCG)
    BALSLEV, I
    AXELSSON, CK
    ZEDELER, K
    RASMUSSEN, BB
    CARSTENSEN, B
    MOURIDSEN, HT
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1994, 32 (03) : 281 - 290
  • [6] Berry MichaelJ., 1997, DATA MINING TECHNIQU
  • [7] HISTOLOGICAL GRADING AND PROGNOSIS IN BREAST CANCER - A STUDY OF 1409 CASES OF WHICH 359 HAVE BEEN FOLLOWED FOR 15 YEARS
    BLOOM, HJG
    RICHARDSON, WW
    [J]. BRITISH JOURNAL OF CANCER, 1957, 11 (03) : 359 - &
  • [8] Buchholz TA., 2003, RADIAT ONCOL, V8th, P333
  • [9] Prognostic value of HER-23/neu and p53 expression in node-positive breast cancer.: HER-2/neu effect on adjuvant tamoxifen treatment
    Climent, MA
    Seguí, MA
    Peiró, G
    Molina, R
    Lerma, E
    Ojeda, B
    López-López, JJ
    Alonso, C
    [J]. BREAST, 2001, 10 (01) : 67 - 77
  • [10] COX DR, 1972, J R STAT SOC B, V34, P187